{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:14:34Z","timestamp":1783689274698,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00436-022-07539-y","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T04:05:36Z","timestamp":1652155536000},"page":"2009-2017","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Exogenous IL-13 exacerbates Leishmania major infection and abrogates acquired immunity to re-infection"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1868-8811","authenticated-orcid":false,"given":"Muriel T.","family":"Zaatar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Simaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc C.","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"7539_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fimmu.2012.00080","volume":"3","author":"J Alexander","year":"2012","unstructured":"Alexander J, Brombacher F (2012) T helper1\/t helper2 cells and resistance\/susceptibility to leishmania infection: is this paradigm still relevant? Front Immunol 3:80. https:\/\/doi.org\/10.3389\/fimmu.2012.00080","journal-title":"Front Immunol"},{"issue":"5","key":"7539_CR2","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J et al (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 7(5):e35671. https:\/\/doi.org\/10.1371\/journal.pone.0035671","journal-title":"PLoS ONE"},{"issue":"3","key":"7539_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.22092\/ari.2020.352245.1555","volume":"76","author":"F Ayrom","year":"2021","unstructured":"Ayrom F, Rasouli S, Shemshadi B (2021) In vitro antileishmanial activity of Achillea santolina essential oil against Leishmania infantum promastigote by methylthiazole tetrazolium (MTT) and trypan blue colorimetric methods. Arch Razi Inst 76(3):529\u2013536. https:\/\/doi.org\/10.22092\/ari.2020.352245.1555","journal-title":"Arch Razi Inst"},{"issue":"11","key":"7539_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ni725","volume":"2","author":"T Biedermann","year":"2001","unstructured":"Biedermann T et al (2001) IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB\/c mice. Nat Immunol 2(11):1054\u20131060. https:\/\/doi.org\/10.1038\/ni725","journal-title":"Nat Immunol"},{"issue":"5069","key":"7539_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1126\/science.1636090","volume":"257","author":"PA Bretscher","year":"1992","unstructured":"Bretscher PA et al (1992) Establishment of stable, cell-mediated immunity that makes \u201csusceptible\u201d mice resistant to Leishmania major. Science(New York, NY) 257(5069):539\u2013542. https:\/\/doi.org\/10.1126\/science.1636090","journal-title":"Science (New York, NY)"},{"issue":"4","key":"7539_CR6","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.4049\/jimmunol.160.4.1666","volume":"160","author":"B de Saint-Vis","year":"1998","unstructured":"de Saint-Vis B et al (1998) The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol (Baltimore Md:1950) 160(4):1666\u20131676","journal-title":"J Immunol (Baltimore Md:1950)"},{"issue":"3","key":"7539_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0255-0857(21)02344-6","volume":"24","author":"A Dey","year":"2006","unstructured":"Dey A, Singh S (2006) Transfusion transmitted leishmaniasis: a case report and review of literature. Indian J Med Microbiol 24(3):165\u2013170","journal-title":"Indian J Med Microbiol"},{"key":"7539_CR8","doi-asserted-by":"publisher","first-page":"2496713","DOI":"10.1155\/2020\/2496713","volume":"2020","author":"T Dubie","year":"2020","unstructured":"Dubie T, Mohammed Y (2020) Review on the role of host immune response in protection and immunopathogenesis during cutaneous leishmaniasis infection. J Immunol Res 2020:2496713. https:\/\/doi.org\/10.1155\/2020\/2496713","journal-title":"J Immunol Res"},{"issue":"1","key":"7539_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.exppara.2011.09.015","volume":"130","author":"TC Felizardo","year":"2012","unstructured":"Felizardo TC et al (2012) Lack of signaling by IL-4 or by IL-4\/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice. Exp Parasitol 130(1):48\u201357. https:\/\/doi.org\/10.1016\/j.exppara.2011.09.015","journal-title":"Exp Parasitol"},{"key":"7539_CR10","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3389\/fimmu.2017.01354","volume":"8","author":"R Hurdayal","year":"2017","unstructured":"Hurdayal R, Brombacher F (2017) Interleukin-4 receptor alpha: from innate to adaptive immunity in murine models of cutaneous leishmaniasis. Front Immunol 8:1354. https:\/\/doi.org\/10.3389\/fimmu.2017.01354","journal-title":"Front Immunol"},{"issue":"2","key":"7539_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.exppara.2013.02.005","volume":"134","author":"MC Karam","year":"2013","unstructured":"Karam MC et al (2013) In Leishmania major-induced inflammation, interleukin-13 reduces hyperalgesia, down-regulates IL-1\u03b2 and up-regulates IL-6 in an IL-4 independent mechanism. Exp Parasitol 134(2):200\u2013205. https:\/\/doi.org\/10.1016\/j.exppara.2013.02.005","journal-title":"Exp Parasitol"},{"issue":"6","key":"7539_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/20477724.2016.1232042","volume":"110","author":"N Maspi","year":"2016","unstructured":"Maspi N, Abdoli A, Ghaffarifar F (2016) Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review. Pathog Glob Health 110(6):247\u2013260. https:\/\/doi.org\/10.1080\/20477724.2016.1232042","journal-title":"Pathog Glob Health"},{"issue":"3","key":"7539_CR13","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.4049\/jimmunol.164.3.1458","volume":"164","author":"DJ Matthews","year":"2000","unstructured":"Matthews DJ et al (2000) IL-13 is a susceptibility factor for Leishmania major infection. J Immunol (Baltimore Md:1950) 164(3):1458\u20131462. https:\/\/doi.org\/10.4049\/jimmunol.164.3.1458","journal-title":"J Immunol (Baltimore Md:1950)"},{"issue":"3","key":"7539_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/s1074-7613(00)80625-1","volume":"9","author":"GJ McKenzie","year":"1998","unstructured":"McKenzie GJ et al (1998) Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9(3):423\u2013432. https:\/\/doi.org\/10.1016\/s1074-7613(00)80625-1","journal-title":"Immunity"},{"issue":"1","key":"7539_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1590\/s0074-02762007000100013","volume":"102","author":"RO Pinheiro","year":"2007","unstructured":"Pinheiro RO, Rossi-Bergmann B (2007) Interferon-gamma is required for the late but not early control of Leishmania amazonensis infection in C57Bl\/6 mice. Mem Inst Oswaldo Cruz 102(1):79\u201382. https:\/\/doi.org\/10.1590\/s0074-02762007000100013","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"43","key":"7539_CR16","doi-asserted-by":"publisher","first-page":"15551","DOI":"10.1073\/pnas.0505630102","volume":"102","author":"A Sakthianandeswaren","year":"2005","unstructured":"Sakthianandeswaren A et al (2005) The wound repair response controls outcome to cutaneous leishmaniasis. Proc Natl Acad Sci USA 102(43):15551\u201315556. https:\/\/doi.org\/10.1073\/pnas.0505630102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"7539_CR17","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.micinf.2004.05.024","volume":"6","author":"E von Stebut","year":"2004","unstructured":"von Stebut E, Udey MC (2004) Requirements for Th1-dependent immunity against infection with Leishmania major. Microbes Infect 6(12):1102\u20131109. https:\/\/doi.org\/10.1016\/j.micinf.2004.05.024","journal-title":"Microbes Infect"},{"issue":"2","key":"7539_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","volume":"16","author":"M Zimmermann","year":"1983","unstructured":"Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16(2):109\u2013110. https:\/\/doi.org\/10.1016\/0304-3959(83)90201-4","journal-title":"Pain"},{"issue":"23","key":"7539_CR19","doi-asserted-by":"publisher","first-page":"13869","DOI":"10.1074\/jbc.270.23.13869","volume":"270","author":"SM Zurawski","year":"1995","unstructured":"Zurawski SM et al (1995) The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 270(23):13869\u201313878. https:\/\/doi.org\/10.1074\/jbc.270.23.13869","journal-title":"J Biol Chem"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-022-07539-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-022-07539-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-022-07539-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T19:50:34Z","timestamp":1675540234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-022-07539-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["7539"],"URL":"https:\/\/doi.org\/10.1007\/s00436-022-07539-y","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"13 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}